Harmony Biosciences Holdings, Inc.
A biopharmaceutical company in Plymouth Meeting, Pennsylvania, that makes WAKIX (pitolisant), a medication for narcolepsy that helps people with the sleep disorder stay awake and controls sudden muscle weakness (cataplexy). Founded in 2017 by Paragon Biosciences, the company licensed the drug's U.S. rights from the French firm Bioprojet. The brand name WAKIX is a play on the word "wake," and unlike many narcolepsy treatments, it is not a controlled substance.
Granted 18.8K
Granted 7.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Budur KumarCHIEF MEDICAL OFFICER · 2 transactions | +1139.6% | 33.0K | 18.8K | — | — |
| Zaeske Adam H.CHIEF COMMERCIAL OFFICER · 2 transactions | — | 4.3K | 7.5K | — | — |
Select a row to see that insider’s individual transactions.